About the Company : Sekhmet Pharmaventures Pvt. Ltd., an Indian subsidiary of Gamot API Pte. Ltd., is backed by prominent private equity firms including PAG, CX Partners, and Samara Capital. The compa...
Sekhmet Pharmaventures Pvt. Ltd., an Indian subsidiary of Gamot API Pte. Ltd., is backed by prominent private equity firms including PAG, CX Partners, and Samara Capital. The company has acquired majority stakes in Anjan Drug (2020) and Optimus Drugs (2022), and is investing in new manufacturing facilities focused on APIs and formulations. With this strategy, Sekhmet aims to become a leading integrated pharma platform, supporting India's growing role in the global supply chain.